DLL1 levels in cerebrospinal fluid (CSF) and serum of patients with tuberculous meningitis (TBM) were higher than those in the bacterial meningitis, viral meningitis/encephalitis and nondiagnosed groups, indicating that DLL1 may be a new biomarker for TBM diagnosis (12). This evidence concerns the gene DLL1 and viral encephalitis.